Key Takeaways STRL is projected to post Q2 EPS of $2.26 on revenues of $555.1M, suggesting a 4.8% y/y fall.Results will likely reflect data center demand, strong backlog and steady transportation activity.Revenues are likely to have been pressured by residential softness, inflation and broader market volatility.Sterling Infrastructure, Inc. (STRL) is scheduled to report second-quarter 2025 results on Aug. 4, after the closing bell.In the last reported quarter, Sterling reported adjusted earnings per share ( ...

In its upcoming report, Yum Brands (YUM) is predicted by Wall Street analysts to post quarterly earnings of $1.45 per share, reflecting an increase of 7.4% compared to the same period last year. Revenues are forecasted to be $1.93 billion, representing a year-over-year increase of 9.5%.The current level reflects an upward revision of 0.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial proj ...

In its upcoming report, Nutrien (NTR) is predicted by Wall Street analysts to post quarterly earnings of $2.40 per share, reflecting an increase of 2.6% compared to the same period last year. Revenues are forecasted to be $10.61 billion, representing a year-over-year increase of 4.5%.Over the last 30 days, there has been an upward revision of 14.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial fo ...

Key Takeaways MAS reported Q2 EPS of $1.30 and revenue of $2.05B, topping estimates despite a slight sales decline.Plumbing segment sales rose 5% and EBITDA climbed to $303M, up from $276M in the prior-year quarter.Adjusted operating margin rose 100 bps to 20.1%, with EBITDA increasing to $449M from $437M last year.Masco Corporation (MAS) posted its second-quarter 2025 results, with both earnings and revenues beating the Zacks Consensus Estimate. Following the results, the company’s shares are up 10% in the ...

银行-外国板块股票比较 - 文章核心观点为比较Bancolombia(CIB)和Banco Itau(ITUB)两只被低估的银行股，通过估值指标分析认为CIB当前更具投资价值 [1][6] 研究方法论 - 采用Zacks Rank评级系统(侧重盈利预测及修正)结合Style Scores价值评分模型(筛选特定特质股票) [2] - 两家公司当前Zacks Rank均为2(买入)，表明盈利前景改善 [3] 估值指标分析 - 关键估值指标包括P/E、PEG、P/B比率及每股现金流等基础财务数据 [4] - CIB远期P/E为6.81低于ITUB的8.60，PEG比率0.96亦优于ITUB的0.97 [5] - CIB市净率(P/B)1.26显著低于ITUB的1.88 [6] 综合评估结果 - CIB获得Style Scores价值评分B级，ITUB为D级 [6] - 基于估值指标对比，CIB当前被视为更优的价值投资选择 [6]

季度业绩预期 - 预计WEC Energy Group季度每股收益为0.71美元，同比增长6% [1] - 预计季度营收为18.6亿美元，同比增长4.9% [1] - 过去30天内，分析师对每股收益的共识预期下调了1.1% [2] 营收细分预测 - 威斯康星州受监管公用事业业务营收预计达14.2亿美元，同比增长4.1% [5] - 伊利诺伊州受监管公用事业业务营收预计为2.746亿美元，同比下降0.8% [5] - 总公用事业业务营收预计为17.8亿美元，同比增长3.6% [6] - 非公用事业能源基础设施业务营收预计为1.8933亿美元，同比增长7.8% [6] - 其他州受监管公用事业业务营收预计为7912万美元，同比增长11.4% [7] 市场表现 - 过去一个月WEC Energy股价上涨6.2%，同期标普500指数上涨4.9% [7] - 公司Zacks评级为3级(持有)，预计未来表现将与整体市场一致 [7]

The upcoming report from Tradeweb Markets (TW) is expected to reveal quarterly earnings of $0.86 per share, indicating an increase of 22.9% compared to the year-ago period. Analysts forecast revenues of $510.25 million, representing an increase of 26% year over year.The consensus EPS estimate for the quarter has been revised 0.8% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Bef ...

关于作者背景 - 作者Emily Jarvie曾在澳大利亚社区媒体担任政治记者 后转至加拿大多伦多报道新兴迷幻药领域的商业、法律和科学发展 [1] - 作者作品发表于澳大利亚、欧洲和北美多家报纸、杂志及数字出版物 包括The Examiner、The Advocate和The Canberra Times等 [1] 关于出版商 - Proactive提供快速、易懂且可操作的全球商业和金融新闻内容 由经验丰富的独立新闻团队制作 [2] - 公司在全球主要金融中心设有分支机构 包括伦敦、纽约、多伦多、温哥华、悉尼和珀斯 [2] 内容覆盖领域 - 专注于中小市值公司 同时覆盖蓝筹股、大宗商品及其他投资领域 [3] - 报道范围包括生物科技、制药、矿业、自然资源、电池金属、石油天然气、加密货币及新兴数字和电动汽车技术 [3] 技术应用 - 采用前瞻性技术辅助工作流程 同时保持人类创作者的核心地位 [4] - 偶尔使用自动化工具和生成式AI 但所有内容均由人类编辑和撰写 [5]

核心财务预测 - 公司预计季度每股收益(EPS)为2.22美元，同比增长6.2% [1] - 预计季度营收达50.5亿美元，同比增长5.9% [1] - 过去30天内分析师将EPS共识预估下调0.1% [2] 细分业务收入预测 - 客户资金利息收入预计2.8631亿美元，同比增长3.4% [5] - PEO业务收入预计16.3亿美元，同比增长5.2% [5] - 非利息/PEO的其他收入预计31.3亿美元，同比增长6.3% [6] 部门业绩展望 - 雇主服务部门收入预计34.3亿美元，同比增长6.4% [6] - PEO服务部门收入预计16.3亿美元，同比增长5% [7] - PEO在职员工平均人数预计757人，较上年同期742人有所增长 [7] 市场表现比较 - 公司股价过去1个月上涨1.1%，同期标普500指数上涨4.6% [7] - 当前Zacks评级为3级(持有)，预计未来表现与大盘同步 [7]

核心财务预测 - 默克公司预计季度每股收益(EPS)为1.99美元，同比下降12.7% [1] - 预计季度营收为157.1亿美元，同比下降2.5% [1] - 过去30天内分析师对EPS共识预期下调1.1% [2] 关键产品线销售预测 - 抗癌药Keytruda预计销售额79亿美元，同比增长8.7% [5] - 疫苗Gardasil预计销售额13亿美元，同比大幅下降47.5% [5] - 动物保健业务预计销售额15.5亿美元，同比增长4.5% [5] 区域销售细分 - Keytruda美国市场预计销售额46.7亿美元，同比增长5.9% [6] - Keytruda国际市场预计销售额31.6亿美元，同比增长10.4% [6] - 抗癌药Lenvima预计总销售额2.44亿美元，同比下降2% [6] 合作产品表现 - Lynparza美国市场预计销售额1.41亿美元，同比下降8% [7] - Lynparza国际市场预计销售额1.85亿美元，同比增长12.4% [7] - Lenvima美国市场预计销售额1.78亿美元，同比增长0.7% [8] - Lenvima国际市场预计销售额7372万美元，同比增长1% [8] 医院急症护理产品 - Zerbaxa美国市场预计销售额3685万美元，同比增长11.7% [9] - Zerbaxa国际市场预计销售额2997万美元，同比增长7.1% [9] 市场表现 - 过去一个月默克股价上涨5.4%，略低于标普500指数5.7%的涨幅 [9]